Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Pharmaceutical Research|February 1, 1996
Erythrocytes and the transport of drugs and endogenous compoundsM S Highley, E A De BruijnJournal of Chromatography|October 12, 1990
Chromatographic analysis of anticancer drugsU R Tjaden, E A de BruijnBiochemical Pharmacology|January 15, 1991
Activation and cytotoxicity of 5'-deoxy-5-fluorouridine in c-H-ras transformed NIH 3T3 cellsY Geng, E Gheuens, E A de BruijnOnkologie|June 1, 1990
Bioavailability of cyclophosphamide in the CMF regimenE Gheuens, P H Slee, E A de BruijnInternational Journal of Cancer|April 22, 1991
The CMF-regimen. Toxicity patterns following stepwise combinations of cyclophosphamide, methotrexate and fluorouracilE A De Bruijn, O M Driessen, J HermansInternational Journal of Cancer|May 15, 1990
The CMF-regimen. Modulation of cyclophosphamide uptake and clearance by methotrexate and fluorouracilE A De Bruijn, Y Geng, J Hermans, et al.Pharmaceutisch Weekblad. Scientific Edition|August 23, 1985
Predictive testing in cancer chemotherapy. II. In vitroP H Slee, A T Van Oosterom, E A De BruijnPharmaceutisch Weekblad. Scientific Edition|June 21, 1985
Predictive testing in cancer chemotherapy. I. In vivoP H Slee, A T Van Oosterom, E A De BruijnJournal of Pharmaceutical and Biomedical Analysis|January 1, 1989
Structural characterization of cisplatin analogues by fast atom bombardment (FAB) and laser microprobe mass spectrometry (LAMMA)J Claereboudt, B De Spiegeleer, E A de Bruijn, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1994
Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2'-deoxyuridineH J Keizer, E A De Bruijn, U R Tjaden, et al.Pageof 9